Financial Data and Key Metrics Changes - The company reported revenue of $48.1 million for Q1 2024, reflecting a year-over-year growth of 17.3% [45][71] - Adjusted EBITDA for the quarter was $9.2 million, representing a 61% increase compared to Q1 2023, with an adjusted EBITDA margin of 19.1% [71][45] - Annual Recurring Revenue (ARR) reached $190.5 million, up 14% year-over-year [69] - The company experienced a net dollar retention (NDR) rate of 103%, an increase of 80 basis points from the previous quarter [97] Business Line Data and Key Metrics Changes - The Average Contract Value (ACV) increased from $219,000 to $226,000, marking a 3.2% quarter-over-quarter and 7.8% year-over-year growth [15] - The Americas region saw a revenue growth of 16% year-over-year, while the EMEA region experienced a 29% year-over-year growth, up from 24% in the previous quarter [16][22] - In the Asia-Pacific region, revenue grew 13% year-over-year, which is lower than the 20% growth seen last year [51] Market Data and Key Metrics Changes - 44% of new clients in EMEA came from outside the U.K., up from 27% in Q1 2023, indicating a strategic expansion into Continental Europe [89] - The company noted capital outflows from China and Hong Kong into Singapore, India, Japan, and Dubai, reflecting shifting market dynamics [64][116] Company Strategy and Development Direction - The company aims to achieve revenue growth of over 20% in the medium term, defined as 2025 to 2027, supported by current macro trends [44] - Enfusion is focused on product innovation, customer satisfaction, and creating superior value for shareholders, with a disciplined approach to capital allocation [36][92] - The company is investing in expanding its account management and managed service teams while enhancing its product capabilities [66] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's ability to execute its strategy, with client onboarding satisfaction scores at three-year highs [13][92] - The operating environment remains volatile, with expectations for increased activity in markets like Dubai and a ramp-up in activity post-Lunar New Year in China [14][34] - Management remains cautious about the impact of recent churn and downgrades but is confident in the overall guidance for the year [104][128] Other Important Information - The company ended the quarter with approximately $33 million in cash and cash equivalents and no outstanding debt, providing adequate liquidity for growth objectives [73] - Adjusted free cash flow for the quarter was negative $1.2 million, impacted by the timing of annual incentives [72] Q&A Session Summary Question: How is the company thinking about resource allocation with the salesforce? - The company is looking to expand its salesforce, particularly in Europe, where there are significant opportunities [103] Question: What is the importance of larger customers in relation to ACV growth? - As the company moves upstream to larger asset managers, ACV will naturally increase, but some churn from smaller clients also contributes to this growth [106] Question: Can you elaborate on the partnership ecosystem and its impact on value services? - The company is leveraging partnerships to enhance its value proposition and provide integrated solutions to clients [108] Question: What are the implications of elevated churn in Q1 on future outlook? - Elevated churn was noted, but the impact was less significant than anticipated as it primarily involved smaller clients [128] Question: How does the company view the market dynamics in APAC? - The company recognizes the unique nuances in the APAC market and is adjusting its strategies accordingly, focusing on capital flows and regional opportunities [114][116]
Enfusion(ENFN) - 2024 Q1 - Earnings Call Transcript